Iron Triangle Partners
Latest statistics and disclosures from Iron Triangle Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACHC, EW, DXCM, GKOS, ELAN, and represent 33.17% of Iron Triangle Partners's stock portfolio.
- Added to shares of these 10 stocks: EW (+$67M), PODD (+$53M), DHR (+$47M), BMRN (+$46M), INSP (+$38M), MCK (+$32M), ELAN (+$29M), INSM (+$28M), TWST (+$26M), AGL (+$17M).
- Started 9 new stock positions in TWST, AGL, BMRN, EW, DHR, PODD, INSM, ALMS, INSP.
- Reduced shares in these 10 stocks: , , ALGN (-$47M), ILMN (-$45M), BRKR (-$44M), APLS (-$32M), FTRE (-$32M), AVTR (-$29M), Shockwave Med (-$26M), SNDX (-$23M).
- Sold out of its positions in ALGN, APLS, AVTR, BRKR, CYTK, EXAS, FTRE, ILMN, XBI, Shockwave Med. SNDX, NYXH, ICLR.
- Iron Triangle Partners was a net buyer of stock by $26M.
- Iron Triangle Partners has $984M in assets under management (AUM), dropping by 0.75%.
- Central Index Key (CIK): 0001779763
Tip: Access up to 7 years of quarterly data
Positions held by Iron Triangle Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Iron Triangle Partners
Iron Triangle Partners holds 24 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Acadia Healthcare (ACHC) | 7.8 | $77M | +25% | 1.1M | 67.54 |
|
| Edwards Lifesciences (EW) | 6.8 | $67M | NEW | 727k | 92.37 |
|
| Dex (DXCM) | 6.7 | $66M | +23% | 582k | 113.38 |
|
| Glaukos (GKOS) | 6.1 | $60M | +18% | 508k | 118.35 |
|
| Elanco Animal Health Call Option (ELAN) | 5.7 | $56M | +103% | 3.9M | 14.43 |
|
| Intuitive Surgical Com New (ISRG) | 5.5 | $54M | -2% | 121k | 444.85 |
|
| McKesson Corporation (MCK) | 5.5 | $54M | +146% | 92k | 584.04 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 5.5 | $54M | +19% | 3.3M | 16.25 |
|
| Insulet Corporation (PODD) | 5.4 | $53M | NEW | 264k | 201.80 |
|
| Abbvie (ABBV) | 5.0 | $49M | +3% | 285k | 171.52 |
|
| Danaher Corporation (DHR) | 4.7 | $47M | NEW | 187k | 249.85 |
|
| BioMarin Pharmaceutical (BMRN) | 4.6 | $46M | NEW | 555k | 82.33 |
|
| West Pharmaceutical Services (WST) | 4.5 | $44M | +11% | 133k | 329.39 |
|
| Brookdale Senior Living (BKD) | 4.0 | $40M | 5.8M | 6.83 |
|
|
| Inspire Med Sys (INSP) | 3.8 | $38M | NEW | 282k | 133.83 |
|
| Oscar Health Cl A (OSCR) | 2.9 | $29M | +37% | 1.8M | 15.82 |
|
| Insmed Com Par $.01 (INSM) | 2.8 | $28M | NEW | 413k | 67.00 |
|
| Neurocrine Biosciences (NBIX) | 2.8 | $28M | -9% | 200k | 137.67 |
|
| Argenx Se Sponsored Adr (ARGX) | 2.7 | $27M | +37% | 62k | 430.04 |
|
| Twist Bioscience Corp (TWST) | 2.6 | $26M | NEW | 527k | 49.28 |
|
| Schrodinger (SDGR) | 2.2 | $22M | +31% | 1.1M | 19.34 |
|
| Agilon Health (AGL) | 1.7 | $17M | NEW | 2.5M | 6.54 |
|
| 908 Devices (MASS) | 0.4 | $3.8M | -29% | 729k | 5.15 |
|
| Alumis (ALMS) | 0.2 | $1.7M | NEW | 125k | 13.30 |
|
Past Filings by Iron Triangle Partners
SEC 13F filings are viewable for Iron Triangle Partners going back to 2019
- Iron Triangle Partners 2024 Q2 filed Aug. 14, 2024
- Iron Triangle Partners 2024 Q1 filed May 15, 2024
- Iron Triangle Partners 2023 Q4 filed Feb. 14, 2024
- Iron Triangle Partners 2023 Q3 filed Nov. 14, 2023
- Iron Triangle Partners 2023 Q2 filed Aug. 14, 2023
- Iron Triangle Partners 2023 Q1 filed May 15, 2023
- Iron Triangle Partners 2022 Q4 filed Feb. 14, 2023
- Iron Triangle Partners 2022 Q3 filed Nov. 14, 2022
- Iron Triangle Partners 2022 Q2 filed Aug. 15, 2022
- Iron Triangle Partners 2022 Q1 filed May 16, 2022
- Iron Triangle Partners 2021 Q4 filed Feb. 14, 2022
- Iron Triangle Partners 2021 Q3 filed Nov. 15, 2021
- Iron Triangle Partners 2021 Q2 filed Aug. 16, 2021
- Iron Triangle Partners 2021 Q1 filed May 17, 2021
- Iron Triangle Partners 2020 Q4 filed Feb. 16, 2021
- Iron Triangle Partners 2020 Q3 filed Nov. 16, 2020